News from the FDA/CDC
News from the FDA/CDC
Single bivalent COVID booster is enough for now: CDC
Booster strength wanes after a few months, spurring discussions of whether people at high risk of getting a severe case of COVID may need more...
News from the FDA/CDC
FDA approves OTC naloxone, but will cost be a barrier?
“The major question is what is it going to cost. In order for people to access it they have to be able to afford it,”
News from the FDA/CDC
COVID led to rise in pregnancy-related deaths: New research
The rise in deaths was most pronounced among Black mothers.
News from the FDA/CDC
FDA approves new formulation of Hyrimoz adalimumab biosimilar
The agency approved a higher-concentration formulation of Hyrimoz for its previous indications, including rheumatoid arthritis and psoriasis.
News from the FDA/CDC
Prostate cancer drug shortage leaves some with uncertainty
The therapy lutetium Lu 177 vipivotide tetraxetan will remain in limited supply until the drug’s manufacturer can ramp up production.
News from the FDA/CDC
Cases of potentially deadly fungus jump 200%: CDC
People in hospitals and nursing homes are at a heightened risk because they might have weakened immune systems or be using invasive medical...
News from the FDA/CDC
HIV testing still suboptimal
“If we just look at the need for HIV testing based on who is at risk, I think that we are always going to fall short.”
News from the FDA/CDC
Children and COVID: A look back as the fourth year begins
Incidence measures continue to decline after the winter without a tripledemic.
News from the FDA/CDC
FDA moves to stop the spread of illicit ‘tranq’ in the U.S.
The agency “remains concerned about the increasing prevalence of xylazine mixed with illicit drugs,” said FDA Commissioner Robert M. Califf, MD....
News from the FDA/CDC
FDA strengthens mammography regulations: Final rule
A final rule requires that mammography facilities notify patients about the density of their breasts.
News from the FDA/CDC
FDA expands abemaciclib use in high-risk early breast cancer
The new expansion removes the Ki-67 testing requirement.